266 related articles for article (PubMed ID: 16019621)
1. Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens.
Griffiths CE; Maddin S; Wiedow O; Marks R; Donald AE; Kahlon G
J Dermatolog Treat; 2005 Apr; 16(2):79-86. PubMed ID: 16019621
[TBL] [Abstract][Full Text] [Related]
2. A randomized and controlled trial about the use of oral isotretinoin for photoaging.
Bagatin E; Parada MO; Miot HA; Hassun KM; Michalany N; Talarico S
Int J Dermatol; 2010 Feb; 49(2):207-14. PubMed ID: 20465648
[TBL] [Abstract][Full Text] [Related]
3. Clinical panel assessment of photodamaged skin treated with isotretinoin using photographs.
Armstrong RB; Lesiewicz J; Harvey G; Lee LF; Spoehr KT; Zultak M
Arch Dermatol; 1992 Mar; 128(3):352-6. PubMed ID: 1550367
[TBL] [Abstract][Full Text] [Related]
4. A controlled multi-center study evaluating the efficacy of Vivité skin care in the treatment of photoaging of the face, eye and mouth.
Goldman MP; Gold MH
J Drugs Dermatol; 2010 Jan; 9(1):22-6. PubMed ID: 20120421
[TBL] [Abstract][Full Text] [Related]
5. Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized study.
Holzer G; Riegler E; Hönigsmann H; Farokhnia S; Schmidt JB
Br J Dermatol; 2005 Sep; 153(3):626-34. PubMed ID: 16120154
[TBL] [Abstract][Full Text] [Related]
6. Tazarotene 0.1% cream for the treatment of photodamage.
Phillips TJ
Skin Therapy Lett; 2004 Apr; 9(4):1-2. PubMed ID: 15146262
[TBL] [Abstract][Full Text] [Related]
7. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
[TBL] [Abstract][Full Text] [Related]
8. Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
Machtinger LA; Kaidbey K; Lim J; Loven KH; Rist TE; Wilson DC; Parizadeh DD; Sefton J; Holland JM; Walker PS
Br J Dermatol; 2004 Dec; 151(6):1245-52. PubMed ID: 15606521
[TBL] [Abstract][Full Text] [Related]
9. Specific gel-cream as adjuvant to oral isotretinoin improved hydration and prevented TEWL increase--a double-blind, randomized, placebo-controlled study.
Herane MI; Fuenzalida H; Zegpi E; De Pablo C; Espadas MJ; Trullás C; Mirada A; Martin GG
J Cosmet Dermatol; 2009 Sep; 8(3):181-5. PubMed ID: 19735515
[TBL] [Abstract][Full Text] [Related]
10. Effect of a preparation containing a fucose-rich polysaccharide on periorbital wrinkles of human voluntaries.
Robert C; Robert AM; Robert L
Skin Res Technol; 2005 Feb; 11(1):47-52. PubMed ID: 15691259
[TBL] [Abstract][Full Text] [Related]
11. Reduction in facial photodamage by a topical growth factor product.
Mehta RC; Smith SR; Grove GL; Ford RO; Canfield W; Donofrio LM; Flynn TC; Leyden JJ
J Drugs Dermatol; 2008 Sep; 7(9):864-71. PubMed ID: 19112801
[TBL] [Abstract][Full Text] [Related]
12. A stabilized 0.1% retinol facial moisturizer improves the appearance of photodamaged skin in an eight-week, double-blind, vehicle-controlled study.
Tucker-Samaras S; Zedayko T; Cole C; Miller D; Wallo W; Leyden JJ
J Drugs Dermatol; 2009 Oct; 8(10):932-6. PubMed ID: 19852122
[TBL] [Abstract][Full Text] [Related]
13. Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected].
Watson RE; Ogden S; Cotterell LF; Bowden JJ; Bastrilles JY; Long SP; Griffiths CE
Br J Dermatol; 2009 Aug; 161(2):419-26. PubMed ID: 19438432
[TBL] [Abstract][Full Text] [Related]
14. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel.
Sefton J; Kligman AM; Kopper SC; Lue JC; Gibson JR
J Am Acad Dermatol; 2000 Oct; 43(4):656-63. PubMed ID: 11004622
[TBL] [Abstract][Full Text] [Related]
15. A novel treatment option for photoaged skin.
Knott A; Koop U; Mielke H; Reuschlein K; Peters N; Muhr GM; Lenz H; Wensorra U; Jaspers S; Kolbe L; Raschke T; Stäb F; Wenck H; Gallinat S
J Cosmet Dermatol; 2008 Mar; 7(1):15-22. PubMed ID: 18254806
[TBL] [Abstract][Full Text] [Related]
16. A double-blind randomized study comparing the association of Retinol and LR2412 with tretinoin 0.025% in photoaged skin.
Bouloc A; Vergnanini AL; Issa MC
J Cosmet Dermatol; 2015 Mar; 14(1):40-6. PubMed ID: 25603890
[TBL] [Abstract][Full Text] [Related]
17. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
18. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
Chajchir I; Modi P; Chajchir A
Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
[TBL] [Abstract][Full Text] [Related]
19. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
Seckin D; Gurbuz O; Akin O
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
